| AMSilk GmbH. (1/20/17). "Press Release: An Innovative High-performance Material – Biofibers Made from Green Lacewing Silk". |
2017-01-20 |
| Affimed N.V.. (1/20/17). "Press Release: Affimed Announces Pricing of Public Offering of Common Stock". Heidelberg. |
2017-01-20 |
| CureVac AG. (1/20/17). "Press Release: CureVac’s CEO, Ingmar Hoerr, Appointed by European Commission to High Level Group". Tübingen. |
2017-01-20 |
| Merck KGaA. (1/20/17). "Press Release: Merck and Genea Open Centre of Excellence for Fertility [This press release is not intended for U.S. based media]". Darmstadt. |
2017-01-20 |
| Oncopeptides AB. (1/19/17). "Press Release: First Patients Are Now Enrolled in HORIZON, Oncopeptides’ Phase II Clinical Trial in Late Stage Relapsed and Refractory Multiple Myeloma". |
2017-01-19 |
| Gyros Protein Technologies AB. (1/19/17). "Press Release: Gyros Protein Technologies Appoints Gerrit van den Dool to Board of Directors". Uppsala. |
2017-01-19 |
| bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux and Banyan Biomarkers Partner to Develop, Validate and Market Blood-Based Biomarkers for Traumatic Brain Injury". Marcy l’Étoile & San Diego, CA. |
2017-01-19 |
| bioMérieux S.A.. (1/19/17). "Press Release: bioMérieux – Fourth-Quarter 2016 Business Review". Marcy l’Étoile. |
2017-01-19 |
| Evotec AG. (1/19/17). "Press Release: Evotec Enters into an Integrated Drug Discovery Collaboration with Asahi Kasei Pharma (Japan)". Hamburg. |
2017-01-19 |
| GlaxoSmithKline plc. (1/19/17). "Press Release: Abbas Hussain to Leave GSK". London. |
2017-01-19 |
| GlaxoSmithKline plc. (1/19/17). "Press Release: Luke Miels Appointed President, Global Pharmaceuticals, GSK". London. |
2017-01-19 |
| Genedata AG. (1/19/17). "Press Release: Genedata Launches Data Science Services for Precision Medicine". Basel. |
2017-01-19 |
| Affimed N.V.. (1/19/17). "Press Release: Affimed Announces Proposed Public Offering of Common Stock". Heidelberg. |
2017-01-19 |
| Cristal Delivery B.V. (d/b/a Cristal Therapeutics). (1/19/17). "Press Release: Cristal Therapeutics Raises €12.8 Million in New Financing Round to Advance Novel Medicines against Cancer Using Its CriPec Nanotech Platform". Maastricht. |
2017-01-19 |
| Elementar UK Ltd.. (1/19/17). "Press Release: Isoprime Ltd Is Changing to Elementar UK". |
2017-01-19 |
| Qiagen N.V.. (1/19/17). "Press Release: Qiagen Announces Intention to Adjust the Conversion Ratio under Its 0.375% Senior Unsecured Convertible Notes due 2019 and Its 0.875% Senior Unsecured Convertible Notes due 2021". Venlo. |
2017-01-19 |
| Octimet Oncology N.V.. (1/19/17). "Press Release: Octimet Oncology NV Secures over EUR 11 Million to Develop Its Highly Selective MET kinase Inhibitors". Beerse. |
2017-01-19 |
| Genenta Science S.r.l.. (1/19/17). "Press Release: Carlo Russo, M.D., Joins Genenta Science as Chief Medical Officer". Milan. |
2017-01-19 |
| Agilent Technologies Inc.. (1/18/17). "Press Release: Agilent Technologies Extends Collaboration on Reproductive Genetics". Santa Clara, CA. |
2017-01-18 |
| Sanofi S.A.. (1/18/17). "Press Release: Suliqua Approved in the European Union for the Treatment of Adults with Type 2 Diabetes". Paris. |
2017-01-18 |
| SGS S.A.. (1/18/17). "Press Release: SGS Opens New Consumer Products Testing Lab in Hai Phong, Vietnam". |
2017-01-18 |
| Merck KGaA. (1/18/17). "Press Release: Merck Launches First Commercial Screening Service to Predict Multiple Sources of DNA Damage". Darmstadt. |
2017-01-18 |
| Qiagen N.V.. (1/18/17). "Press Release: Qiagen Announces Details for Completion of approximately $250 Million Synthetic Share Repurchase". Venlo. |
2017-01-18 |
| Lysogene S.A.. (1/18/17). "Press Release: Lysogene Receives Rare Pediatric Disease Designation from FDA for LYS-GM101 for Treatment of GM1 Gangliosidosis". Paris & Cambridge, MA. |
2017-01-18 |
| Minoryx Therapeutics S.L.. (1/18/17). "Press Release: Minoryx Therapeutics Further Strengthens Its Scientific Advisory Board (SAB)". Mataró, Barcelona. |
2017-01-18 |
| Eli Lilly and Company. (1/18/17). "Press Release: Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid". Indianapolis, IN & Cambridge, MA. |
2017-01-18 |
| Evotec AG. (1/17/17). "Press Release: Evotec and MaRS Innovation Establish Strategic Partnership to Launch Fibrocor Therapeutics". Toronto, ON & Hamburg. |
2017-01-17 |
| ObsEva S.A.. (1/17/17). "Press Release: ObsEva Expands Leadership Team and Board of Directors with Industry Veterans". Geneva. |
2017-01-17 |
| Protagen AG. (1/17/17). "Press Release: The German National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG Investigate Responsiveness to Checkpoint Inhibitors in Melanoma". |
2017-01-17 |
| Indivumed GmbH. (1/17/17). "Press Release: Northwell Health Partners with Indivumed to Create a Cancer Research Biobank". Hamburg. |
2017-01-17 |
| InfectoGnostics Forschungscampus Jena e. V.. (1/17/17). "Press Release: MicrobeDx Europe Founded in Jena". |
2017-01-17 |
| Mologen AG. (1/17/17). "Press Release: Convertible Bond Worth €4.99 Million Successfully Placed [Not for United States, Australia, Canada or Japan, et al.]". Berlin. |
2017-01-17 |
| PharmaFluidics N.V.. (1/17/17). "Press Release: PharmaFluidics Raises 2.7 Million Euro to Commercialize Novel Micro-chip Device for Biomarker, Diagnostics and Drug Development Applications". Ghent. |
2017-01-17 |
| Bavarian Nordic A/S. (1/17/17). "Press Release: Henrik Birk Appointed Chief Operating Officer of Bavarian Nordic". Copenhagen. |
2017-01-17 |
| Congenica Ltd.. (1/17/17). "Press Release: Congenica Expands in North America with Strategic Appointment. Genomics Analysis Leader Appoints Dr Shikha O’Brien as Chief Business Officer". Cambridge. |
2017-01-17 |
| Oncurious N.V.. (1/17/17). "Press Release: Oncurious NV Announces European Commission Confirmed Orphan Medicinal Product Designation for TB-403 for Medulloblastoma". Leuven. |
2017-01-17 |
| Lytix Biopharma AS. (1/13/17). "Press Release: Lytix Biopharma Announces the Appointment of Torbjørn Furuseth as CFO". |
2017-01-13 |
| Dentons. (1/13/17). "Press Release: Dentons Represents Bayer – Further Sentences in the World's Largest Trial against Drug Counterfeiters". Frankfurt a. M. & Potsdam. |
2017-01-13 |
| Eppendorf AG. (1/13/17). "Press Release: William Linton Is New Member of the Supervisory Board". Hamburg. |
2017-01-13 |
| ObsEva S.A.. (1/13/17). "Press Release: ObsEva Announces Completion of Phase 1 First-in-Women Study of OBE022 for the Treatment of Preterm Labor". Geneva. |
2017-01-13 |
| Silence Therapeutics plc. (1/13/17). "Press Release: Minority Stake in Arrowhead Pharmaceuticals". London. |
2017-01-13 |
| MorphoSys AG. (1/12/17). "Press Release: MorphoSys Partner to Start Phase 2 Trial with Bimagrumab in Obese Patients with Type 2 Diabetes". Planegg. |
2017-01-12 |
| Optibrium Ltd.. (1/12/17). "Press Release: Optibrium and eMolecules Collaborate on Chemistry Data Integration in StarDrop". Cambridge & La Jolla, CA. |
2017-01-12 |
| Luxendo GmbH. (1/12/17). "Press Release: Luxendo Announces Series A Extension Bringing Total Capital Raised to €8 Million". Heidelberg. |
2017-01-12 |
| Evotec AG. (1/12/17). "Press Release: Haplogen’s Novel Antiviral Target Partnered with Evotec Published in »Nature«". Vienna, Amsterdam & Hamburg. |
2017-01-12 |
| Merck KGaA. (1/12/17). "Press Release: Merck and Palantir Launch New Healthcare Acceleration Partnership". Palo Alto, CA & Darmstadt. |
2017-01-12 |
| CureVac AG. (1/11/17). "Press Release: CureVac Provides Clinical Update at 35th Annual J.P. Morgan Healthcare Conference". San Francisco, CA & Tübingen. |
2017-01-11 |
| Affimed N.V.. (1/11/17). "Press Release: Affimed Provides Update on NK-Cell Immuno-Oncology Platform". Heidelberg. |
2017-01-11 |
| Intellia Therapeutics, Inc.. (1/11/17). "Press Release: Intellia Therapeutics Joins Genomics England’s Industry Consortium". Cambridge, MA & London. |
2017-01-11 |
| ViroVet N.V.. (1/10/17). "Press Release: ViroVet Successfully Raises €5 Million in Series A Funding". |
2017-01-10 |
| Merck KGaA. (1/10/17). "Press Release: Merck Expands End-to-End Biodevelopment Centers in North America, China and Europe". Darmstadt. |
2017-01-10 |
| Genedata AG. (1/10/17). "Press Release: Genedata Partners with Crescendo Biologics on Next-generation Immuno-Oncology and ADC Programs". Basel. |
2017-01-10 |
| Tecan Group Ltd.. (1/10/17). "Press Release: Tecan Appoints Klaus Lun Head of the Life Sciences Business Division". Männedorf. |
2017-01-10 |
| Indivumed GmbH. (1/10/17). "Press Release: Indivumed Joins Blood Profiling Atlas in Cancer (Blood PAC)". Hamburg. |
2017-01-10 |
| Mologen AG. (1/10/17). "Press Release: Grant to Collaboration Partner for Combination Study in HIV with Lead Product Lefitolimod. Gilead Sciences, Inc. Grant for Aarhus University Hospital". Berlin. |
2017-01-10 |
| AstraZeneca plc. (1/10/17). "Press Release: AstraZeneca Receives EU Approval of Fasenra for Severe Eosinophilic Asthma". |
2017-01-10 |
| Macrophage Pharma Ltd.. (1/9/17). "Press Release: Macrophage Pharma Raises £9 Million in Series A Financing and Acquires Immune-oncology Technology Platform". Windsor. |
2017-01-09 |
| Abivax S.A.. (1/9/17). "Press Release: Abivax to Receive €8.4 Million from Bpifrance “Invest in the Future Program” (PIA) for the Development of Innovative Antiviral Drugs". Paris. |
2017-01-09 |
| Kymab Group Ltd.. (1/9/17). "Press Release: Kymab Expands Infectious Disease Programmes. Kymab Receives $9m Grant from the Bill & Melinda Gates Foundation to Fund Infectious Disease Research and Development". Cambridge. |
2017-01-09 |
| F2G Ltd.. (1/9/17). "Press Release: F2G Ltd Receives European Orphan Drug Designation for its Lead Candidate F901318". Manchester. |
2017-01-09 |
| Immunic AG. (1/9/17). "Press Release: Immunic Strengthens Management Team and Supervisory Board". Planegg-Martinsried. |
2017-01-09 |
| Royal Philips. (1/9/17). "Press Release: Philips and Illumina Join Forces to Offer Integrated Genomics Solutions for Oncology". Amsterdam & San Diego, CA. |
2017-01-09 |
| IntegraGen S.A.. (1/9/17). "Press Release: IntegraGen Reports Sharp Increase in Sales during 2016". Évry. |
2017-01-09 |
| Eternygen GmbH. (1/9/17). "Press Release: Eternygen GmbH Closes € 8.0 (US$ 8.3) Million Series A Financing led by Epidarex Capital". Berlin. |
2017-01-09 |
| Merck KGaA. (1/9/17). "Press Release: Merck and MD Anderson Cancer Center Enter Three-Year Strategic Collaboration". Darmstadt. |
2017-01-09 |
| ImmuNext, Inc.. (1/9/17). "Press Release: Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases". Bridgewater, NJ & Lebanon, NH. |
2017-01-09 |
| Evotec AG. (1/9/17). "Press Release: Evotec and Eternygen to Develop Novel Metabolic Disease Therapy". Hamburg. |
2017-01-09 |
| Qiagen N.V.. (1/9/17). "Press Release: Qiagen Enhances Bioinformatics Portfolio with Acquisition of OmicSoft". Hilden & Germantown, MD. |
2017-01-09 |
| Roche. (1/9/17). "Press Release: FDA Grants Roche’s Cancer Immunotherapy Tecentriq (atezolizumab) Priority Review in Additional Type of Advanced Bladder cancer". Basel. |
2017-01-09 |
| McDermott Will & Emery. (1/9/17). "Press Release: McDermott Will & Emery Advised Servier in Its Strategic Immuno-oncology Co-development Alliance with Pieris Pharmaceuticals". Paris. |
2017-01-09 |
| Ipsen S.A.. (1/9/17). "Press Release: Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals". Paris. |
2017-01-09 |
| Immatics Biotechnologies GmbH. (1/9/17). "Press Release: Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies". Thousand Oaks, CA & Tübingen. |
2017-01-09 |
| Silence Therapeutics plc. (1/9/17). "Press Release: Acquisition of Minority Stake in Arrowhead Pharmaceuticals". London. |
2017-01-09 |
| Anokion S.A.. (1/8/17). "Press Release: Anokion Announces Exclusive Strategic Collaboration with Celgene to Develop Novel Tolerance-inducing Therapeutics for Autoimmune Diseases". Lausanne & Cambridge, MA. |
2017-01-08 |
| Noxxon Pharma N.V.. (1/6/17). "Press Release: Half-yearly Report on the Liquidity Contract with Invest Securities". Berlin. |
2017-01-06 |
| McDermott Will & Emery. (1/6/17). "Press Release: McDermott Will & Emery Advised Servier in Its License Option Agreement with OSE Immunotherapeutics". Paris. |
2017-01-06 |
| Silence Therapeutics plc. (6/1/17). "Press Release: Hiring of Chief Operating Officer". |
2017-01-06 |
| Owlstone Medical Ltd.. (1/6/17). "Press Release: Owlstone Medical Announces $11.55m USD Fundraising". Cambridge. |
2017-01-06 |
| Xigen S.A.. (1/5/17). "Press Release: Xigen’s Brimapitide, an Innovative JNK Inhibitor, Delivers Positive Phase II Results in Inflammatory Eye Disease". Geneva. |
2017-01-05 |
| Valneva S.E.. (1/5/17). "Press Release: Valneva Announces a New Research License Agreement with MSD Animal Health for the Development of Vaccines in the EB66 Cell Line". Lyon. |
2017-01-05 |
| HepaRegenix GmbH. (1/5/17). "Press Release: HepaRegenix GmbH Raises EUR9 million in a Series A Financing to Develop Kinase Inhibitors for the Treatment of Acute and Chronic Liver Diseases". Tübingen. |
2017-01-05 |
| Phenex Pharmaceuticals AG. (1/5/17). "Press Release: Phenex Receives 100 M USD Milestone Payment from Gilead". Ludwigshafen. |
2017-01-05 |
| Neovacs S.A.. (1/5/17). "Press Release: Neovacs to Collaborate with the Sunnybrook Research Institute for Preclinical Development of VEGF Kinoid to Treat Colorectal Cancer and Ovarian Cancer". Paris & Boston, MA. |
2017-01-05 |
| Nerre Therapeutics Ltd.. (1/5/17). "Press Release: Nerre Therapeutics Raises £23 Million in Oversubscribed Series B Financing Round". Paris & Boston, MA. |
2017-01-05 |
| IDT Biologika GmbH. (1/5/17). "Press Release: IDT Biologika Acquires Ridgeway Biologicals Ltd". Dessau & Compton. |
2017-01-05 |
| MorphoSys AG. (1/5/17). "Press Release: Dr. Malte Peters to Become New Chief Development Officer of MorphoSys AG". Planegg. |
2017-01-05 |
| Pieris Pharmaceuticals, Inc.. (1/5/17). "Press Release: Pieris Pharmaceuticals and Servier Forge Strategic Immuno-oncology Co-development Alliance". Boston, MA & Suresnes. |
2017-01-05 |
| Tecan Group Ltd.. (1/5/17). "Press Release: Tecan to Present at J.P. Morgan Healthcare Conference". Männedorf. |
2017-01-05 |
| Sanofi S.A.. (1/5/17). "Press Release: Sanofi and Regeneron to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent (alirocumab) Injection". Paris & Tarrytown, NY. |
2017-01-05 |
| Kite Pharma, Inc.. (1/5/17). "Press Release: Kite Pharma Enhances Commercial Expertise with the Appointment of Ian T. Clark to Its Board of Directors". Santa Monica, CA. |
2017-01-05 |
| Bicycle Therapeutics Ltd.. (1/5/17). "Press Release: Bicycle Therapeutics Appoints Nicholas Keen, Ph.D., as Chief Scientific Officer". Cambridge, MA & Cambridge. |
2017-01-05 |
| Ablynx N.V.. (1/5/17). "Press Release: Ablynx to Present at the 35th J.P. Morgan Healthcare Conference". Ghent. |
2017-01-05 |
| Iterum Therapeutics Ltd.. (1/5/17). "Press Release: Iterum Announces Sulopenem in Development for Treatment of Gram-Negative, Multi-drug Resistant Infections". Dublin & Chicago, IL. |
2017-01-05 |
| Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of CMO InVivo Biotech to Expand Molecular Biology, Microbiology and Pathology Consumables and Assay Business". Berlin. |
2017-01-04 |
| Bruker Corporation. (1/4/17). "Press Release: Bruker Announces Acquisition of SCiLS GmbH to Advance MALDI Imaging Software Solutions for Life Science, Pharma and Pathology Research Applications". Bremen. |
2017-01-04 |
| Waters Corporation. (1/4/17). "Press Release: Waters CE-Marks In Vitro Diagnostic MassTrak Vitamin D Solution". Milford, MA. |
2017-01-04 |
| AiCuris Anti-infective Cures GmbH. (1/4/17). "Press Release: AiCuris Initiates Clinical Development of AIC499, a Novel Resistance-Breaking Antibiotic against a Broad Range of MDR Gram-Negative Bacteria". Wuppertal. |
2017-01-04 |
| Affimed N.V.. (1/4/17). "Press Release: Affimed and MD Anderson Announce Clinical Immuno-Oncology Development Collaboration". Heidelberg & Houston, TX. |
2017-01-04 |
| Noxxon Pharma N.V.. (1/4/17). "Press Release: Noxxon Pharma Licenses and Assigns Preclinical Spiegelmer Programs to Aptarion. Noxxon Continues Transition to Clinical Oncology Company". Berlin. |
2017-01-04 |
| Merck KGaA. (1/4/17). "Press Release: Merck Acquires BioControl to Strengthen Position in Food Safety Testing". Darmstadt. |
2017-01-04 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 ... 96 97 98 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
